Yeonsun Hong
Yeonsun Hong
Staff scientist, University of Rochester Medicinal Center
Verified email at
Cited by
Cited by
Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
SM Kim, Y Yang, SJ Oh, Y Hong, M Seo, M Jang
Journal of Controlled Release 266, 8-16, 2017
Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis
E Koh, EJ Lee, GH Nam, Y Hong, E Cho, Y Yang, IS Kim
Biomaterials 121, 121-129, 2017
Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery
Y Yang, Y Hong, E Cho, GB Kim, IS Kim
Journal of extracellular vesicles 7 (1), 1440131, 2018
Exosome as a vehicle for delivery of membrane protein therapeutics, PH20, for enhanced tumor penetration and antitumor efficacy
Y Hong, GH Nam, E Koh, S Jeon, GB Kim, C Jeong, DH Kim, Y Yang, ...
Advanced Functional Materials 28 (5), 1703074, 2018
Virus‐mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes
Y Yang, Y Hong, GH Nam, JH Chung, E Koh, IS Kim
Advanced Materials 29 (13), 1605604, 2017
Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics
E Cho, GH Nam, Y Hong, YK Kim, DH Kim, Y Yang, IS Kim
Journal of Controlled Release 279, 326-335, 2018
Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer
GH Nam, EJ Lee, YK Kim, Y Hong, Y Choi, MJ Ryu, J Woo, Y Cho, DJ Ahn, ...
Nature communications 9 (1), 2165, 2018
Nanocage‐therapeutics prevailing phagocytosis and immunogenic cell death awakens immunity against cancer
EJ Lee, GH Nam, NK Lee, M Kih, E Koh, YK Kim, Y Hong, S Kim, SY Park, ...
Advanced materials 30 (10), 1705581, 2018
In situ one-step fluorescence labeling strategy of exosomes via bioorthogonal click chemistry for real-time exosome tracking in vitro and in vivo
S Song, MK Shim, S Lim, Y Moon, S Yang, J Kim, Y Hong, HY Yoon, ...
Bioconjugate chemistry 31 (5), 1562-1574, 2020
Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103+ dendritic cells and in combination with PD-L1 blockade boosts …
Y Hong, YK Kim, GB Kim, GH Nam, SA Kim, Y Park, Y Yang, IS Kim
Journal of Extracellular Vesicles 8 (1), 1670893, 2019
Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics
NK Lee, EJ Lee, S Kim, G Nam, M Kih, Y Hong, C Jeong, Y Yang, Y Byun, ...
Journal of Controlled Release 267, 172-180, 2017
In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic …
S Kim, SA Kim, GH Nam, Y Hong, GB Kim, Y Choi, S Lee, Y Cho, M Kwon, ...
Journal for Immunotherapy of Cancer 9 (1), 2021
Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity
GB Kim, GH Nam, Y Hong, J Woo, Y Cho, IC Kwon, Y Yang, IS Kim
Science Advances 6 (27), eaaz2083, 2020
Identification of novel ROS inducers: quinone derivatives tethered to long hydrocarbon chains
Y Hong, S Sengupta, W Hur, T Sim
Journal of medicinal chemistry 58 (9), 3739-3750, 2015
Mechanically active integrins target lytic secretion at the immune synapse to facilitate cellular cytotoxicity
MS Wang, Y Hu, EE Sanchez, X Xie, NH Roy, M de Jesus, BY Winer, ...
Nature communications 13 (1), 3222, 2022
One step synthesis of quantum dot–magnetic nanoparticle heterodimers for dual modal imaging applications
J Lee, G Hwang, YS Hong, T Sim
Analyst 140 (8), 2864-2868, 2015
An optimized protocol to determine the engulfment of cancer cells by phagocytes using flow cytometry and fluorescence microscopy
GH Nam, Y Hong, Y Choi, GB Kim, YK Kim, Y Yang, IS Kim
Journal of immunological methods 470, 27-32, 2019
Dendritic cell activation by an E. coli-derived monophosphoryl lipid A enhances the efficacy of PD-1 blockade
Y Jeong, GB Kim, Y Ji, GJ Kwak, GH Nam, Y Hong, S Kim, J An, SH Kim, ...
Cancer letters 472, 19-28, 2020
Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer
H Kim, HJ Park, HW Chang, JH Back, SJ Lee, YE Park, EH Kim, Y Hong, ...
Bioactive Materials 25, 527-540, 2023
The therapeutic potential of immune cell-derived exosomes as an alternative to adoptive cell transfer
Y Hong, IS Kim
BMB reports 55 (1), 39, 2022
The system can't perform the operation now. Try again later.
Articles 1–20